首页> 美国卫生研究院文献>Scientific Reports >Immunoinformatics approaches to explore Helicobacter Pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine
【2h】

Immunoinformatics approaches to explore Helicobacter Pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine

机译:免疫信息学方法探索幽门螺杆菌蛋白质组(毒力因子)以设计B和T细胞多表位亚单位疫苗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Helicobacter Pylori is a known causal agent of gastric malignancies and peptic ulcers. The extremophile nature of this bacterium is protecting it from designing a potent drug against it. Therefore, the use of computational approaches to design antigenic, stable and safe vaccine against this pathogen could help to control the infections associated with it. Therefore, in this study, we used multiple immunoinformatics approaches along with other computational approaches to design a multi-epitopes subunit vaccine against H. Pylori. A total of 7 CTL and 12 HTL antigenic epitopes based on c-terminal cleavage and MHC binding scores were predicted from the four selected proteins (CagA, OipA, GroEL and cagA). The predicted epitopes were joined by AYY and GPGPG linkers. Β-defensins adjuvant was added to the N-terminus of the vaccine. For validation, immunogenicity, allergenicity and physiochemical analysis were conducted. The designed vaccine is likely antigenic in nature and produced robust and substantial interactions with Toll-like receptors (TLR-2, 4, 5, and 9). The vaccine developed was also subjected to an in silico cloning and immune response prediction model, which verified its efficiency of expression and the immune system provoking response. These analyses indicate that the suggested vaccine may produce particular immune responses against H. pylori, but laboratory validation is needed to verify the safety and immunogenicity status of the suggested vaccine design.
机译:幽门螺杆菌是胃恶性肿瘤和消化性溃疡的已知病因。这种细菌的极端嗜热性保护着它免于设计出针对它的有效药物。因此,使用计算方法来设计针对该病原体的抗原性,稳定和安全的疫苗可以帮助控制与之相关的感染。因此,在这项研究中,我们使用了多种免疫信息学方法以及其他计算方法来设计针对幽门螺杆菌的多表位亚基疫苗。从四个选定的蛋白质(CagA,OipA,GroEL和cagA)预测了基于c末端切割和MHC结合评分的总共7个CTL和12个HTL抗原表位。预测的表位由AYY和GPGPG接头连接。将α-防御素佐剂添加到疫苗的N-末端。为了验证,进行了免疫原性,变应原性和理化分析。设计的疫苗可能具有抗原性,并与Toll样受体(TLR-2、4、5和9)产生牢固而充分的相互作用。开发的疫苗还接受了计算机克隆和免疫应答预测模型,从而验证了其表达效率和激发免疫系统的应答。这些分析表明,建议的疫苗可能产生针对幽门螺杆菌的特定免疫反应,但是需要实验室验证以验证建议的疫苗设计的安全性和免疫原性状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号